new tech

AI-backed retail energy startup based in Houston prepares to grow its technology

Houston-based Evolve Energy uses a subscription-based wholesale energy plan to help its customers find better prices for more sustainable resources. Photo via evolvemyenergy.com

A wholesale retail energy startup based in Houston is preparing to scale its artificial intelligence-backed business based on its positive customer feedback

Evolve Energy uses AI and machine learning to optimize energy usage, providing customers with the best wholesale energy prices on fluctuating renewable resources.

"We want to help our customers save a significant amount of money on electricity costs and help them decarbonize the grid," CEO Michael Lee tells InnovationMap."There's been a serious of emerging events that enable us to do both at the same time, it's no longer a choice."

Evolve Energy, founded in 2018, sells wholesale electricity at cost to residential customers in Texas, charging a $10 monthly subscription fee plus the cost of wholesale electricity. Using their AI technology, they predict when price surges are likely and determine how much energy the customer needs to hit the parameters set on the app by the customer and usage history. The customer does not need to do anything but pair Evolve with their smart thermostat.

According to Lee, this enables customers to continue to use the same volume of electricity but cut their bill by 40 percent over the course of a year. Evolve uses a different business model, positioning itself not as energy providers but as efficient energy managers, passing their wholesale rate with no markup for even more savings to the customer.

"It builds a lot of trust between the customer and the supplier, they truly see that our incentive is to save them money and not to sell them any more power," Lee says.

With the increasing trend of electrification, Lee sees the role of energy companies grow in importance. This gives energy managers like Evolve a magnified role as machine learning and AI becomes imperative to shift consumption when renewables are cheaper on the grid.

Evolve is backed by several investors including Matt Rogers, the original co-founder of Nest thermostats through his investment platform, Incite; Urban-X funded by BMW MINI which focuses on smart applications; and the Austin-based startup accelerator and investor, Capital Factory.

The company has been officially on the market for the past two months, but it's already working on deploying capital to build in features requested by customers. Evolve expects significant growth in the next few years due to its highly scalable model.

"I'm just glad we could create a product that no longer makes it a choice between reducing emissions and saving money," Lee says.

Trending News

Building Houston

 
 

San Diego-based rBIO moved to Houston to take advantage of the growing ecosystem of biomanufacturing and synthetic biology. Photo via Getty Images

Cameron Owen had an idea for a synthetic biology application, and he pitched it to a handful of postdoctoral programs. When he received the feedback that he didn't have enough research experience, he decided to launch a startup based in San Diego around his idea. He figured that he'd either get the experience he needed to re-apply, or he'd create a viable company.

After three years of research and development, Owen's path seems to have taken him down the latter of those two options, and he moved his viable company, rBIO, to Houston — a twist he didn't see coming.

“Houston was not on my radar until about a year and a half ago,” Owen says, explaining that he thought of Houston as a leading health care hub, but the coasts still had an edge when it came to what he was doing. “San Diego and the Boston area are the two big biotech and life science hubs.”

But when he visited the Bayou City in December of 2021, he says he saw first hand that something new was happening.

“Companies from California like us and the coastal areas were converging here in Houston and creating this new type of bioeconomy,” he tells InnovationMap.

Owen moved to Houston last year, but rBIO still has an academic partner in Washington University in St. Louis and a clinical research organization it's working with too, so he admits rBIO's local footprint is relatively small — but not for long.

"When we look to want to get into manufacturing, we definitely want to build something here in Houston," he says. "We’re just not to that point as a company."

In terms of the stage rBIO is in now, Owen says the company is coming out of R&D and into clinical studies. He says rBIO has plans to fundraise and is meeting with potential partners that will help his company scale and build out a facility.

With the help of its CRO partner, rBIO has two ongoing clinical projects — with a third coming next month. Owen says right now rBIO is targeting the pharmaceutical industry’s biologics sector — these are drugs our bodies make naturally, like insulin. About 12 percent of the population in the United States has diabetes, which translates to almost 40 million people. The demand for insulin is high, and rBIO has a way to create it — and at 30 percent less cost.

This is just the tip of the iceberg — the world of synthetic biology application is endless.

“Now that we can design and manipulate biology in ways we’ve never been able to before,” Owen says, "we’re really only limited by our own imagination.”

Synthetic biology is a field of science that involves programing biology to create and redesign natural elements. While it sounds like science fiction, Owen compares it to any other type of technology.

“Biology really is a type of software,” he says. “Phones and computers at their core run on 1s and 0s. In biology, it’s kind of the same thing, but instead of two letters, it’s four — A, C, T, and G.”

“The cool thing about biology is the software builds the hardware,” he continues. “You put that code in there and the biology builds in and of itself.”

Owen says the industry of synthetic biology has been rising in popularity for years, but the technology has only recently caught up.

“We’re exploring a brave new world — there’s no doubt about that,” Owen says.

Trending News